FOLLOW US

  • facebook
  • twitter
Fri

March 13, 2026

primeGen us to go public

America February 4, 2026

primeGen US to Go Public in $1.5 Billion SPAC Deal

Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm…

By Rachel Moore

PicS Nasdaq IPO

America January 6, 2026

PicS Nasdaq IPO Filed as Brazilian Digital Bank Eyes Wall Street

Like a fintech heavyweight stepping onto a global stage, PicS has formally filed for a U.S. initial public offering, signaling…

By Rihem Akkouche

Avalanche Treasury $675M SPAC Merger

America October 6, 2025

Avalanche Treasury $675M SPAC Merger Targets Institutional Crypto Surge

In a bold step bridging Wall Street and blockchain, Mountain Lake Acquisition Corp. announced plans to merge with Avalanche Treasury…

By Rihem Akkouche

Horizon Quantum merges with dMY

America September 9, 2025

Horizon Quantum Merges With dMY in $503M Nasdaq Deal

Horizon Quantum Computing Pte. Ltd., a fast-rising developer of quantum software, announced Tuesday it will go public through a $503…

By Rihem Akkouche

IRocket $400M SPAC Merger

America July 23, 2025

iRocket to Go Public in $400M SPAC Merger

In a bold leap toward the stars—and the Nasdaq—Innovative Rocket Technologies Inc., better known as iRocket, has announced a $400…

By Rihem Akkouche

Global Terra Raises $152M IPO

America July 9, 2025

Globa Terra Launches $152M SPAC IPO for Agri-Water Deals

Globa Terra Acquisition Corp. hit the Nasdaq trading floor Wednesday, raising $152 million through its initial public offering, a bold…

By Rihem Akkouche

Bgin Blockchain Files $50M IPO

America February 22, 2025

Bgin Blockchain Files $50M IPO, Aims to Expand Crypto Mining Empire

Cryptocurrency mining company Bgin Blockchain Ltd. has officially entered the race for public capital, filing for a $50 million initial…

By Rihem Akkouche

Aardvark $94M IPO

America February 13, 2025

Aardvark Lands $94M IPO as Biotech Wave Gains Momentum

Aardvark Therapeutics Inc. made its public market debut Thursday, securing $94 million in its initial public offering (IPO). The obesity-focused…

By Rihem Akkouche

Bicara Therapeutics $200M IPO

America September 6, 2024

Bicara Therapeutics $200M IPO for Cancer Drug Development

Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…

By Rihem Akkouche

CubeBio $375M Merger

America August 30, 2024

CubeBio $375M Merger with Mountain Crest Acquisition Corp. V

Mountain Crest Acquisition Corp. V, a blank check company advised by Loeb & Loeb LLP, has announced a merger agreement…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter